A share price of Inari Medical Inc [NARI] is currently trading at $52.20, up 1.26%. An important factor to consider is whether the stock is rising or falling in short-term value. The NARI shares have gain 2.70% over the last week, with a monthly amount glided 6.68%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Inari Medical Inc [NASDAQ: NARI] stock has seen the most recent analyst activity on September 18, 2024, when Stifel initiated its Hold rating and assigned the stock a price target of $50. Previously, Leerink Partners started tracking the stock with Market Perform rating on September 03, 2024, and set its price target to $47. On August 09, 2024, Deutsche Bank initiated with a Buy rating and assigned a price target of $68 on the stock. William Blair started tracking the stock assigning a Outperform rating. Needham downgraded its rating to a Hold. Piper Sandler downgraded its rating to Neutral for this stock on February 29, 2024, and downed its price target to $55. In a note dated January 23, 2024, Needham initiated an Buy rating and provided a target price of $72 on this stock.
Inari Medical Inc experienced fluctuations in its stock price throughout the past year between $36.73 and $67.13. Currently, Wall Street analysts expect the stock to reach $64 within the next 12 months. Inari Medical Inc [NASDAQ: NARI] shares were valued at $52.20 at the most recent close of the market. An investor can expect a potential return of 22.61% based on the average NARI price forecast.
Analyzing the NARI fundamentals
Trailing Twelve Months sales for Inari Medical Inc [NASDAQ:NARI] were 574.50M which represents 21.39% growth. Gross Profit Margin for this corporation currently stands at 0.86% with Operating Profit Margin at -0.08%, Pretax Profit Margin comes in at -0.09%, and Net Profit Margin reading is -0.14%. To continue investigating profitability, this company’s Return on Assets is posted at -0.11, Equity is -0.18 and Total Capital is -0.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 51.20 points at the first support level, and at 50.21 for the second support level. However, for the 1st resistance point, the stock is sitting at 52.76, and for the 2nd resistance point, it is at 53.33.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Inari Medical Inc [NASDAQ:NARI] is 1.77. On the other hand, the Quick Ratio is 1.40, and the Cash Ratio is 0.28. Considering the valuation of this stock, the price to sales ratio is 5.32, the price to book ratio is 7.02.
Transactions by insiders
Recent insider trading involved Hykes Andrew, President and CEO, that happened on Nov 20 ’24 when 3000.0 shares were sold. Director, Hoffman William completed a deal on Nov 18 ’24 to sell 60000.0 shares. Meanwhile, Director WILLIAM HOFFMAN bought 0.12 million shares on Nov 18 ’24.
